ELIZABETH MILLER: Open Payments
NPI 1730568601 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 61 payments from 17 companies in 2025. Trend: 2023 $414 · 2024 $882 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 21 | $202 |
| LEO Pharma Inc. | 7 | $148 |
| ABBVIE INC. | 5 | $112 |
| GENZYME CORPORATION | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $55 |
| PFIZER INC. | 3 | $52 |
| Amgen Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
Products named: Bimzelx, DUPIXENT, ADBRY, Winlevi, CIBINQO, OTEZLA, EBGLYSS, RINVOQ.
Industry payments across FL — which companies pay providers there.
